NAPOLI, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 1.753
EU - Europa 523
AS - Asia 253
SA - Sud America 6
OC - Oceania 1
Totale 2.536
Nazione #
US - Stati Uniti d'America 1.752
SE - Svezia 218
CN - Cina 162
IT - Italia 109
SG - Singapore 72
DE - Germania 47
UA - Ucraina 44
FI - Finlandia 33
GB - Regno Unito 33
FR - Francia 18
BE - Belgio 12
VN - Vietnam 9
IN - India 7
BR - Brasile 4
IE - Irlanda 4
MY - Malesia 2
NL - Olanda 2
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
CO - Colombia 1
LT - Lituania 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 2.536
Città #
Fairfield 252
Chandler 208
Nyköping 160
Ashburn 129
Woodbridge 120
Houston 105
Seattle 103
Jacksonville 99
Ann Arbor 89
Cambridge 85
Wilmington 80
Beijing 49
New York 42
Singapore 40
Lawrence 33
Roxbury 33
Nanjing 30
Des Moines 25
Brooklyn 24
Ostuni 20
Boardman 19
Princeton 18
Nanchang 15
Bari 14
Brussels 12
Santa Clara 11
Dong Ket 9
Inglewood 9
Hanover 8
Munich 8
Shenyang 8
Helsinki 7
Jiaxing 7
Rome 7
Hebei 6
San Diego 6
Tianjin 6
Zhengzhou 5
Changsha 4
Dearborn 4
Dublin 4
Frankfurt am Main 4
Guangzhou 4
London 4
Los Angeles 4
Noci 4
Pune 4
Taizhou 4
Taranto 4
Kunming 3
Ningbo 3
Paris 3
Redwood City 3
Shanghai 3
Andria 2
Baotou 2
Casalnuovo di Napoli 2
Cesa 2
Falls Church 2
Kuala Lumpur 2
Norwalk 2
Pistoia 2
San Pietro Vernotico 2
São Paulo 2
Vigodarzere 2
Washington 2
Auburn Hills 1
Auckland 1
Augusta 1
Bragança 1
Casalnuovo Di Napoli 1
Chicago 1
Colle 1
Cordoba 1
Cosenza 1
Haikou 1
Hefei 1
Hounslow 1
Kilburn 1
Landshut 1
Modugno 1
Monmouth Junction 1
New Bedfont 1
Oslo 1
Pozzallo 1
Prescot 1
Rivoli 1
San Martino Valle Caudina 1
San Mateo 1
Santiago de Cali 1
Sirmione 1
Sofia 1
Soresina 1
São Vicente 1
Triggiano 1
Wenzhou 1
Yong'an 1
Totale 2.015
Nome #
Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study 133
Kikuchi-Fujimoto Disease in an Old Italian Woman: Case Report and Review of the Literature 130
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 119
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 117
Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β 114
SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience 112
Sierotipi del virus dell'epatite C e focalità tumorale in pazienti con cirrosi epatica HCV-correlata ed epatocarcinoma 109
A pegylated interferon alpha-2b dose-reduction in HCV 1b patients with rapid virological response does not affect sustained virological response 107
A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage 105
Hepatocellular Carcinoma: Known and Emerging Risk Factors 103
Apoptotic effects of a chimeric plant virus carrying a mimotope of the hepatitis C virus hypervariable region 1: role of caspases and endoplasmic reticulum-stress. 97
Hepatocytes activate HSC via MMP-9. Role of IFN-a2b in modulating liver fibrosis in HCV patients 94
Biliary Cystadenoma in a Female Patient with HCV-Related Liver Cirrhosis: A Case Report 86
Impairment of TLR7-dependent signaling in dendritic cells from chronic hepatitis C virus (HCV)-infected non-responders to interferon/ribavirin therapy 84
Hepatitis C virus infection in anti-HBe-positive HBsAg carriers with chronic liver disease 82
Hepatitis A virus and non-A, non-B virus superinfections in HBsAg chronic carriers. 82
Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma 79
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency 77
Manifestazioni extraepatiche multiple in una paziente con epatite cronica C trattata con interferone-alfa 75
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. 73
Occurrence of hepatitis delta virus infection in hepatitis B virus-infected patients with different serum patterns of preS geneencoded proteins 64
Antifibrogenic effect of IFN-alpha2b on hepatic stellate cell activation by human hepatocytes 60
Angiodisplasia gastrica di grave entità in un caso di porpore di Schonlein-Henoch 56
Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C 53
Relationship between T lymphocyte responsiveness and T-helper1/T-helper2 type cytokine release in Chronic Hepatitis C: a critical reappraisal 51
Vasculite sistemica secondaria a trattamento con alfa-interferone in un soggetto con crioglobulinemia mista di tipo II 51
Asymptomatic systemic sarcoidosis arising 5 years after IFN-alfa treatment for chronic hepatitis C: a new challenge for clinicians 47
Analysis of hepatic stiffness after viral eradication in a population with chronic hepatitis C treated with DAAs 44
Clinical role of serum and tissue matrix metalloprotease-9 expression in chronic HCV patients treated with pegylated IFN-alpha2b and ribavirin 42
Ribavirin and high dose of interferon-alfa for retreatment of patients with chronic hepatitis C resistant to IFN alone 40
Relationship between HCV serotypes and tumor focality in HCV-infected cirrhotic patients with HCC 37
Liver fibrosis score, physical frailty, and the risk of dementia in older adults: The Italian longitudinal study on aging 37
The use of different Peg-interferon alpha-2b regimens plus ribavirin in HCV-1b-infected patients after rapid virological response does not affect the achievement of sustained virological response 29
Neutrophil apoptotic cell death: does it contribute to the increased infectious risk in aging? 26
Totale 2.615
Categoria #
all - tutte 10.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.678


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020388 0 0 0 0 60 32 54 50 69 37 73 13
2020/2021404 31 21 23 36 46 15 41 22 28 86 33 22
2021/2022309 22 33 1 13 27 54 12 13 16 13 49 56
2022/2023557 78 80 52 49 66 72 3 61 80 5 6 5
2023/2024205 11 36 10 36 15 66 6 8 1 1 3 12
2024/2025152 21 13 59 35 24 0 0 0 0 0 0 0
Totale 2.615